“…Thus, -509C may selectively downregulate TGF-β1 expression, and increased TGF-ß1 levels may be associated with -509T owing to the loss of negative regulation (Shah et al, 2006). The T allele of the -509C>T polymorphism has been associated with an increased risk of diseases such as endometriosis, asthma, and breast cancer (Zhang et al, 2010;Huang et al, 2011;Lee et al, 2011). Furthermore, the associations of the -509C>T polymorphism with bone mass or osteoporosis have been investigated, both alone and in combination with 869T>C polymorphism, but have yielded inconsistent or contradictory results (Yamada et al, 2001;Langdahl et al, 2003Langdahl et al, , 2008.…”